Browsing Articles and other publications by RIVM employees by Authors
Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017.Ndumbi, Patricia; Freidl, Gudrun S; Williams, Christopher J; Mårdh, Otilia; Varela, Carmen; Avellón, Ana; Friesema, Ingrid; Vennema, Harry; Beebeejaun, Kazim; Ngui, Siew Lin; Edelstein, Michael; Smith-Palmer, Alison; Murphy, Niamh; Dean, Jonathan; Faber, Mirko; Wenzel, Jürgen; Kontio, Mia; Müller, Luise; Midgley, Sofie Elisabeth; Sundqvist, Lena; Ederth, Josefine Lundberg; Roque-Afonso, Anne-Marie; Couturier, Elisabeth; Klamer, Sofieke; Rebolledo, Javiera; Suin, Vanessa; Aberle, Stephan W; Schmid, Daniela; De Sousa, Rita; Augusto, Gonçalo Figueiredo; Alfonsi, Valeria; Del Manso, Martina; Ciccaglione, Anna Rita; Mellou, Kassiani; Hadjichristodoulou, Christos; Donachie, Alastair; Borg, Maria-Louise; Sočan, Maja; Poljak, Mario; Severi, Ettore (2018)Between 1 June 2016 and 31 May 2017, 17 European Union (EU) and European Economic Area countries reported 4,096 cases associated with a multi-country hepatitis A (HA) outbreak. Molecular analysis identified three co-circulating hepatitis A virus (HAV) strains of genotype IA: VRD_521_2016, V16-25801 and RIVM-HAV16-090. We categorised cases as confirmed, probable or possible, according to the EU outbreak case definitions. Confirmed cases were infected with one of the three outbreak strains. We investigated case characteristics and strain-specific risk factors for transmission. A total of 1,400 (34%) cases were confirmed; VRD_521_2016 and RIVM-HAV16-090 accounted for 92% of these. Among confirmed cases with available epidemiological data, 92% (361/393) were unvaccinated, 43% (83/195) travelled to Spain during the incubation period and 84% (565/676) identified as men who have sex with men (MSM). Results depict an HA outbreak of multiple HAV strains, within a cross-European population, that was particularly driven by transmission between non-immune MSM engaging in high-risk sexual behaviour. The most effective preventive measure to curb this outbreak is HAV vaccination of MSM, supplemented by primary prevention campaigns that target the MSM population and promote protective sexual behaviour.
Travel-associated hepatitis A in Europe, 2009 to 2015.Beauté, Julien; Westrell, Therese; Schmid, Daniela; Müller, Luise; Epstein, Jevgenia; Kontio, Mia; Couturier, Elisabeth; Faber, Mirko; Mellou, Kassiani; Borg, Maria-Louise; Friesema, Ingrid; Vold, Line; Severi, Ettore (2018-05)BackgroundTravel to countries with high or intermediate hepatitis A virus (HAV) endemicity is a risk factor for infection in residents of countries with low HAV endemicity. Aim: The objective of this study was to estimate the risk for hepatitis A among European travellers using surveillance and travel denominator data. Methods: We retrieved hepatitis A surveillance data from 13 European Union (EU)/ European Economic Area (EEA) countries with comprehensive surveillance systems and travel denominator data from the Statistical Office of the European Union. A travel-associated case of hepatitis A was defined as any case reported as imported. Results: From 2009 to 2015, the 13 countries reported 18,839 confirmed cases of hepatitis A, of which 5,233 (27.8%) were travel-associated. Of these, 39.8% were among children younger than 15 years. The overall risk associated with travel abroad decreased over the period at an annual rate of 3.7% (95% confidence interval (CI): 0.7-2.7) from 0.70 cases per million nights in 2009 to 0.51 in 2015. The highest risk was observed in travellers to Africa (2.11 cases per million nights). Cases more likely to be reported as travel-associated were male and of younger age (< 25 years). Conclusion: Travel is still a major risk factor for HAV infection in the EU/EEA, although the risk of infection may have slightly decreased in recent years. Children younger than 15 years accounted for a large proportion of cases and should be prioritised for vaccination.
Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018.Gassowski, Martyna; Michaelis, Kai; Wenzel, Jürgen J; Faber, Mirko; Figoni, Julie; Mouna, Lina; Friesema, Ingrid Hm; Vennema, Harry; Avellon, Ana; Varela, Carmen; Sundqvist, Lena; Lundberg Ederth, Josefine; Plunkett, James; Balogun, Koye; Ngui, Siew Lin; Midgley, Sofie Elisabeth; Gillesberg Lassen, Sofie; Müller, Luise (2018-07)From January to June 2018, two ongoing hepatitis A outbreaks affected travellers returning from Morocco and cases in Europe without travel history, resulting in 163 patients in eight European countries. Most interviewed travel-related cases were unaware of the hepatitis A risk in Morocco. Molecular analysis revealed two distinct hepatitis A virus (HAV) strains (subgenotype IA DK2018_231; subgenotype IB V18-16428). Vaccination recommendations should be emphasised to increase awareness among non-immune travellers to Morocco and HAV-endemic countries.